{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Cambridge",
      "state": "MA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "78792",
      "recalling_firm": "Sanofi Genzyme",
      "address_1": "500 Kendall St",
      "address_2": "",
      "postal_code": "02142-1108",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US Nationwide distribution(36 states)",
      "recall_number": "Z-0607-2018",
      "product_description": "Synvisc-One ¿ (hylan G-F 20), 6mL delivered from a 10mL syringe    Product Usage:  A elastoviscous high molecular weight fluid containing hylan A and hylan B polymers produced from chicken combs. Synvisc-One is administered as a single intra-articular injection. Synvisc-One is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.",
      "product_quantity": "12,380 units",
      "reason_for_recall": "Contamination with Methylbacterium thiocyanatum",
      "recall_initiation_date": "20171211",
      "center_classification_date": "20180213",
      "termination_date": "20230403",
      "report_date": "20180221",
      "code_info": "Lot Number: 7RSL021  Expiration Date: 2020-05-31",
      "more_code_info": ""
    }
  ]
}